UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 430-436

  Zhong, Jialing ^a   Zhao, Mei ^a   Ma, Yiming ^a   Luo, Qing ^a   Liu, Jian ^a   Wang, Jia ^a   Yuan, Xinghua ^a   Sang, Jianli ^b   Huang, Changzhi ^a  

^a CANCER HOSPITAL   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

catenin T cell factor pathway; Colorectal cancer; Ubiquitin C terminal hydrolase L1

Indexed keywords

BETA CATENIN; CYCLIN D1; T CELL FACTOR PROTEIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; UBIQUITIN THIOLESTERASE; UP-REGULATION;

EID: 84863545303     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1012     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Levin B and Boyle P (eds): World cancer report 2008. International Agency for Research on Cancer, Lyon, pp374-379, 2008.
3. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, Sato Y, Nishikawa K, Sun YJ, Sakurai M, et al: Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monou biquitin in neuron. Hum Mol Genet 12: 1945-1958, 2003.
4. Setsuie R and Wada K: The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 51: 105-111, 2007.
5. Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ and Lee KJ: Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28: 117-127, 2009.
6. Leiblich A, Cross SS, Catto JW, Pesce G, Hamdy FC and Rehman I: Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. Prostate 67: 1761-1769, 2007.
7. Tezel E, Hibi K, Nagasaka T and Nakao A: PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res 6: 4764-4767, 2000.
8. Li L, Tao Q, Jin H, van Hasselt A, Poon FF, Wang X, Zeng MS, Jia WH, Zeng YX, Chan AT and Cao Y: The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res 16: 2949-2958, 2010.
9. Okochi-Takada E, Nakazawa K, Wakabayashi M, Mori A, Ichimura S, Yasugi T and Ushijima T: Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Int J Cancer 119: 1338-1344, 2006.
10. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MP, et al: Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48: 508-518, 2008.
11. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, et al: PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 65: 4963-4968, 2005.
12. Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, Taguchi T, Tamaki Y and Noguchi S: High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci 97: 523-529, 2006.
13. Takase T, Hibi K, Yamazaki T, Nakayama H, Taguchi M, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A: PGP9.5 overexpression in esophageal squamous cell carcinoma. Hepatogastroenterology 50: 1278-1280, 2003.
14. Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, Tang F, Chen Q, Yang JM, Xu ZD and Liu XP: Overexpression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancercells. Int J Oncol 33: 1037-1045, 2008.
15. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A: PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 8: 192-195, 2002.
16. Ma Y, Zhao M, Zhong J, Shi L, Luo Q, Liu J, Wang J, Yuan X and Huang C: Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. J Cell Biochem 110: 1512-1519, 2010.
17. Larsen CN, Price JS and Wilkinson KD: Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active siteresidues. Biochemistry 35: 6735-6744, 1996.
18. Hiendlmeyer E, Regus S, Wassermann S, Hlubek F, Haynl A, Dimmler A, Koch C, Knoll C, van Beest M, Reuning U, et al: Beta-catenin upregulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res 64: 1209-1214, 2004.
19. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999.
20. Fukutomi S, Seki N, Koda K and Miyazaki M: Identification of methylation-silenced genes in colorectal cancer cell lines genomic screening using oligonucleotide arrays. Scand J Gastroenterol 42: 1486-1494, 2007.
21. Akishima-Fukasawa Y, Ino Y, Nakanishi Y, Miura A, Moriya Y, Kondo T, Kanai Y and Hirohashi S: Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma. Am J Clin Pathol 134: 71-79, 2010.
22. Hong Y, Ho KS, Eu KW and Cheah PY: A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathway: implication for tumorigenesis. Clin Cancer Res 13: 1107-1114, 2007.
23. Mizukami H, Shirahata A, Goto T, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: PGP9.5 methylation as a marker for metastatic colorectal cancer. Anticancer Res 28: 2697-2700, 2008.
24. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
25. Bheda A, Yue W, Gullapalli A, Whitehurst C, Liu R, Pagano JS and Shackelford J: Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS One 4: e5955, 2009.
26. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
27. Mazaud S, Guyot R, Guigon CJ, Coudouel N, Le Magueresse-Battistoni B and Magre S: Basal membrane remodeling during follicle histogenesis in the rat ovary: contribution of proteinases of the MMP and PA families. Dev Biol 277: 403-416, 2005.
28. Morgan H and Hill PA: Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int 5: 1, 2005.